TechInvention® claims positive outcomes of its indigenously developed recombinant subunit SARS-CoV-2 vaccine (CoviTechTM) in a ‘Single Dose’ preliminary study
TechInvention Lifecare Pvt. Ltd., a Biotech start-up company based out of Mumbai, India has claimed positive outcomes of its recombinant subunit SARS-CoV-2 vaccine (CoviTechTM) in a ‘single dose’ preliminary study. In the study involving twenty-four…